Beneficial Effects of a Freeze-Dried Kale Bar on Type 2 Diabetes Patients: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial
Nutrients · 2024
DOI: 10.3390/nu16213641 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2024. Verfasst von Per Bendix Jeppesen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine, Aarhus University, Aarhus University Hospital, 8200 Aarhus N, Denmark. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Brassica, Freeze Drying. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Future Food Innovation, Skejby , Denmark, Future Food Innovation Differentiation Fund.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background/Objectives: Type 2 diabetes (T2D) is one of the most common global diseases, with an ever-growing need for prevention and treatment solutions. Kale (Brassica oleracea L. var. acephala) offers a good source of fiber, minerals, bioavailable calcium, unsaturated fatty acids, prebiotic carbohydrates, vitamins, health-promoting secondary plant metabolites, as well as higher amounts of proteins and essential amino acids compared to other vegetables. The objective of this study was to investigate whether daily intake of freeze-dried kale powder can provide health benefits for T2D patients vs. placebo.
Methods
This study was designed as a 12-week, blinded, randomized, controlled trial. Thirty T2D patients were randomly assigned to either a placebo bar (control) or a kale bar (intervention). Participants in the intervention group were instructed to consume three bars/day, each containing 26.25 g of freeze-dried kale (corresponding to approx. 341 g fresh kale/day). At baseline and 12 weeks, all participants underwent an oral glucose tolerance test (OGTT), 24 h blood pressure measurements, DEXA scans, and fasted blood samples were taken.
Results
A significant reduction in HbA1c, insulin resistance, body weight, and calorie intake was observed in the intervention group compared to control. Positive trends were detected in fasted blood glucose and LDL-cholesterol for those in the kale intervention group. No significant differences were found in total body fat mass and area under the curve glucose 240 min OGTT.
Conclusions
Given the positive effects of high daily kale intake observed in this study, further research with a larger sample size is needed to better understand the health benefits of kale bars. This could potentially lead to new dietary recommendations for patients with T2D.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Medicine, Aarhus University, Aarhus University Hospital, 8200 Aarhus N, Denmark.
- Department of Animal Science, Aarhus University, 8830 Tjele, Denmark.
ORCID-Profile: Per Bendix Jeppesen
Förderung
- Future Food Innovation, Skejby , Denmark
- Future Food Innovation Differentiation Fund
Zitieren
APA
Jeppesen, P. B., Dorner, A., Yue, Y., Poulsen, N., Andersen, S. K., Aalykke, F. B., & Lambert, M. N. T. (2024). Beneficial Effects of a Freeze-Dried Kale Bar on Type 2 Diabetes Patients: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial. Nutrients. https://doi.org/10.3390/nu16213641
Vancouver
Jeppesen PB, Dorner A, Yue Y, Poulsen N, Andersen SK, Aalykke FB, et al. Beneficial Effects of a Freeze-Dried Kale Bar on Type 2 Diabetes Patients: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial. Nutrients. 2024. doi:10.3390/nu16213641
BibTeX
@article{Jeppesen2024,
author = {Jeppesen, Per Bendix and Dorner, Amanda and Yue, Yuan and Poulsen, Nikolaj and Andersen, Sofie Korsgaard and Aalykke, Fie Breenfeldt and Lambert, Max Norman Tandrup},
title = {Beneficial Effects of a Freeze-Dried Kale Bar on Type 2 Diabetes Patients: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16213641}
}
EUVIMED